- PaylessKratom
- Count
- 30 - 49
- ON7 7OH Blend Focus Scripts Tablets, 20MG X 30CT, Blue Raspberry
ON7 7OH Blend Focus Scripts Tablets, 20MG X 30CT, Blue Raspberry
$109.99
Shipping: Orders over $49 ship FREE
Free Standard Shipping – orders over $49 Free USPS Priority shipping – orders over $100
ON7 7OH Blend Focus Scripts Tablets 20mg x 30ct in Blue Raspberry are chewable dual-alkaloid focus tablets designed for experienced adults who want a precise, daily cognitive-support format built around advanced kratom-derived compounds. Each tablet delivers a total of 20mg actives, combining 10mg of 7‑hydroxymitragynine with 10mg of mitragynine pseudoindoxyl to support clarity, concentration, and a steady “locked‑in” feel without traditional stimulant buzz.
Product overview
- Product: ON7 7OH Blend Focus Scripts Tablets
- Strength per tablet: 20mg total
- 10mg 7‑hydroxymitragynine
- 10mg mitragynine pseudoindoxyl
- Count: 30 tablets per bottle (600mg total active blend)
- Flavor: Blue Raspberry – bright, tangy, candy‑like finish
- Positioning: Daily focus and cognitive-support tablet for a full month of use (one tablet per day)
The Blue Raspberry flavor helps soften the naturally bitter edge of concentrated alkaloids, making each chewable more approachable than raw extracts or unflavored tablets.
How it’s formulated to feel
These ON7 Focus tablets are marketed to:
- Enhance concentration and mental clarity, helping you stay sharp during deep work, study sessions, or long meetings
- Support cognitive performance without high-caffeine jitters or an energy-drink crash
- Provide a smooth, focused, “in the zone” experience through the combined activity of 7‑OH and pseudoindoxyl at very small, clearly defined doses
The 20mg total strength per tablet is designed as a targeted, potent micro‑format, not a beginner product.
Use and dosing (conceptual)
The ON7 Focus 30‑count bottle is positioned as a once‑daily focus aid, with each tablet pre‑measured at 20mg combined alkaloids. Typical label structures in this line use:
- One tablet as a daily serving for experienced users, often with the option to start at 1/2 tablet for new users or those with lower tolerance
- A recommendation to allow sufficient time (often 30–120 minutes) before taking more, because 7‑OH and pseudoindoxyl can have a delayed but strong effect
Always follow the exact serving instructions printed on your ON7 Focus bottle and do not exceed the stated daily maximum.
Key benefits highlighted by the brand
- Clarity & focus: Designed to support sustained attention, reduce brain‑fog feelings, and help you stay on task.
- Convenient & portable: Small, easy-to-take tablets that fit in a pocket, bag, or desk drawer for on‑the‑go use.
- Optimized absorption: Formulated with excipients to help active ingredients absorb efficiently.
- Month-long supply: 30 tablets per bottle for consistent, daily use across the month.
Ingredients
- Active alkaloids:
- 7‑Hydroxymitragynine
- Mitragynine pseudoindoxyl
- Other ingredients: Natural excipients (such as common tablet binders and flow agents) selected to support tablet integrity and absorption (see product label for exact list).
Legal and safety notes
7‑hydroxymitragynine and mitragynine pseudoindoxyl are potent kratom-derived compounds that act at opioid receptors and are not FDA‑approved dietary ingredients. Because of this, ON7-style products typically include strong restrictions:
- Age: Not for use or purchase by persons under 21.
- Shipping limits: Many vendors do not ship kratom/7‑OH products to states such as Alabama, Arkansas, Indiana, Rhode Island, Vermont, Wisconsin, and certain municipalities, and may require ID verification in states with stricter rules (for example Florida, Tennessee, Virginia, West Virginia).
- FDA disclaimer: These products do not diagnose, treat, cure, or prevent any disease, and the FDA has not approved kratom, 7‑OH, or mitragynine pseudoindoxyl as dietary supplements.
7‑OH is documented as a potent mu‑opioid receptor agonist with respiratory‑depressant and dependence risks comparable to or greater than some classical opioids. Pseudoindoxyl derivatives are similarly classified as advanced, high‑risk alkaloid formats.
Because of this, ON7 Focus tablets should only be used by informed adults who:
- Read the entire product label and follow all directions exactly
- Avoid combining with alcohol, opioids, sedatives, or interacting medications
- Consult a healthcare professional before use, especially if they have any medical conditions or take prescription drugs
Ingredients: 7-Hydroxymitragynine & Mitragynine Pseudoindoxyl
Other Ingredients: Dextrose, Magnesium, Glycinate, Magnesium Stearate, Artificial Flavor





